Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

Comparative Study Between Effect of Bleomycin Intralesional Injection And Application of Diode Laser on Infantile Hemangioma.

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06510829

Enrollment

Registered

2024-07-19

Start date

2024-09-01

Completion date

2026-10-31

Last updated

2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleomycin Adverse Reaction

Brief summary

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to : * Clinically based on Change in the Size and Color of Hemangioma. * Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology . * Comparison of Complications associated with Bleomycin and Diode Laser.

Interventions

DEVICEDiode laser

Application of laser waves on the lesion

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Months to 12 Months

Healthy volunteers

Yes

Inclusion criteria

* Age between 3 Months and 1 Year old. * Non Complicated Infantile Hemangioma

Exclusion criteria

* Younger than 3 Months or older than 1 Year. * Complicated Infantile Hemangioma

Design outcomes

Primary

Measure	Time frame
Effect of diode laser on hemangioma	3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026